Impaired synaptic inhibition due to decreased KCC2 function has been documented in Huntington’s disease [66], epilepsy [67, 68], neuropathic pain [69] and spasticity following spinal cord injury [70]. This evidence concerns the gene SLC12A5 and Huntington disease.